Trial intelligence / Profile preview

Clomiphene citrate versus recombinant FSH for ovarian stimulation in infertile women undergoing IUI

IRCT201211135181N8Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jan 2015
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label trial of clomiphene and recombinant human follicle stimulating hormone in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Started Jan 2015; status: completed.

02

Drugs

clomiphenerecombinant human follicle stimulating hormone
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT201211135181N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201211135181N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call